Targeting Incretins in Type 2 Diabetes: Role of GLP-1 Receptor Agonists and DPP-4 Inhibitors . Rev Diabet Stud. 2023;5(2). Accessed January 19, 2026. https://www.diabeticstudies.org/index.php/RDS/article/view/287